Pan-Coronavirus Protease Engagement and Differentiated Pharmacology of Antiviral Candidate CMX990
N. G. R. Dayan Elshan, Karen C. Wolff, Laura Riva…·Arnab K. Chatterjee
This study evaluates CMX990, a coronavirus Mpro inhibitor, showing broad antiviral activity against multiple coronaviruses and superior pharmacologic properties compared to existing inhibitors.